Lyra Therapeutics Inc. is a clinical-stage biopharmaceutical company that develops novel therapies to improve the lives of patients with ear, nose and throat (ENT) diseases. Leveraging its proprietary drug delivery platform, Lyra is focused on creating innovative treatments for chronic rhinosinusitis and other ENT conditions.